AusBiotech chief executive Rebekah Cassidy says the idea that Australia is incapable of commercialising biotechnology is outdated and misleading, pointing to a growing cohort of globally competitive companies whose...
Melbourne-headquartered Telix Pharmaceuticals has expanded its United States presence with the acquisition of $73 million in proprietary technology and a research facility from Californian BioTech firm ImaginAb. Telix announced...